United States
Patient Instruction & Fitting Guides
Consumer
Search
Product search
Practitioner home > Our Products > Additional Products > Proclear® sphere

Proclear® sphere

  • Proclear® sphere trial units will be discontinued on November 1, 2026, and revenue packs will be discontinued on November 1, 2027.

Why Switch to Biofinity®? 

Our Biofinity® family of lenses can provide a seamless refit from Proclear® sphere.*1 By upgrading your patients to Biofinity Energys® and Biofinity® XR monthly lenses, you and your patients benefit from:

  • Enhanced patient satisfaction1
  • A healthier lens wearing experience†2
  • Same or better vision performance than Proclear‡§1
  • Incredible, all-day comfort3
  • Patient rebates◊

Biofinity® is the most prescribed4 and most trusted brand of monthly replacement contact lenses, named most trusted more than 4X as often as the next leading brand.¶5

Need Support?

For questions about transitioning patients or product details, please contact your CooperVision® Sales Representative or reach out to our Customer Service team at 800-341-2020.

Also of Interest:

*Seamless refit is: lens fit, comfort, VA. ECPs should use fitting guides to ensure selection of appropriate lens parameters including power.
†With high oxygen delivery for daily wear, SiHy materials minimize or eliminate hypoxia-related complications.
‡ECPs should use fitting guides to ensure selection of appropriate lens parameters including power.
§Based on similar or better comfort, vision performance, handling, and similar lens fit and, where appropriate, toric orientation position.
◊Rebate values subject to change. Rebate valid for purchases through 12/31/26 subject to all rebate terms and conditions. See manufacturer's rebate form for more details.
¶51% of ECPs selected Biofinity® brand contact lenses vs. 12% for second ranked from the widely prescribed lens options provided; 4.3 times more than the next largest brand.
References: 

1. CVI data on file, 2025.
2. CVI data on file, 2024; Sulley A, Dumbleton K. Silicone hydrogel daily disposable benefits: The evidence. CLAE. 2020;43(3):298-307.
3. CVI data on file, 2026.
4. CVI data on file. 2025, industry reports and internal estimates.

5. CVI data on file, 2025. US ECP Online Survey. N= 212 ECPs who fit Biofinity® family products.

20023 07/26